| Issuer | % of Class | Filed |
|---|---|---|
|
Psyence Biomedical Ltd.
13G/A
Amendment 1
PBM · 74449F308
|
2.6% |
6/10/2026
Event 2/25/2026
|
|
Psyence Biomedical Ltd.
13G
PBM · 74449F308
|
5.1% |
2/19/2026
Event 2/13/2026
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.